Although COVID-19 is still disrupting economies around the world, it’s not stopping the long-term trend of Asia’s rapid digitization writes RGP’s Asia-Pacific digital leader, Sachin Shah.
Supply chain expert Ron Rod details how healthcare providers, payers and life sciences companies are responding to COVID-19 supply chain interruptions while preparing to emerge stronger in the future.
The concept of “business as usual” might seem like a quaint oxymoron today. But as we begin moving beyond the first stage of pandemic response, business leaders must reimagine what usual looks like—and be ready to guide transformation during the post-COVID recovery.
Companies in hard-hit sectors like retail were reeling long before the COVID-19 outbreak. The pandemic only added to the pain they were feeling from the impact of e-commerce and other market disruptions. Now, the downward pressure has spread far and wide.
To keep up with rapidly accelerating technology breakthroughs and rising customer expectations, business leaders need the agility to respond to constant change. Agile transformation is a bold move for any organization, but the sooner you begin, the sooner you will realize the benefits.
The ongoing spread of the novel coronavirus and COVID-19 has created an unprecedented level of uncertainty for the entire business world.
Transformative change inevitably brings serious human impacts. That means change management should be a cornerstone of your strategic planning, with a focus on the “people part.”
Now that the Financial Accounting Standards Board (FASB) formally approved a delay in implementing lease accounting for private companies, are you wondering what this means for your organization?
During a carve-out or divestiture, the majority of the seller’s focus is on negotiating the purchase and sale agreement (PSA) and valuation considerations.